Apple
Apple Blood Oxygen Feature Workaround Sparks Fresh Masimo Lawsuit
Apple Watch Oxygen Feature Ignites Masimo Legal Battle
What’s Happening?
Masimo has launched a legal attack on the U.S. Customs and Border Protection over Apple’s reinstated blood oxygen monitoring feature in its smartwatches.
Where Is It Happening?
United States federal court.
When Did It Take Place?
June 2023.
How Is It Unfolding?
– Masimo’s lawsuit challenges the government agency’s approval of Apple’s feature.
– Claims Apple Watch Series 6 and later models infringe on Masimo’s patents.
– Demands Apple cease using the disputed technology.
– Masks the earlier legal skirmish over wearable health tech dominance.
Quick Breakdown
– Masimo alleges patent infringement by Apple’s blood oxygen feature.
– U.S. Customs and Border Protection decision to allow reintroduction is under fire.
– Legal battle reshapes the wearable tech and patent enforcement landscape.
– Impacts Apple Watch users relying on health monitoring capabilities.
Key Takeaways
Masimo’s lawsuit signifies more than a patent dispute—it’s a battle for control over lifesaving health tech in consumer wearables. With blood oxygen monitoring becoming crucial, especially post-pandemic, the case could redefine how such features are regulated. If Masimo wins, Apple may need to redesign its feature or seek a licensing agreement. If Apple prevails, it could set a precedent for future tech patents.
“This isn’t just about technology; it’s about safeguarding innovation and patient safety.”
– Joe Kiani, Masimo Founder and CEO
Final Thought
**The Apple-Masimo legal clash over blood oxygen tech is more than corporate rivalry; it’s a pivotal moment in health-tech evolution. While users hope for seamless health monitoring, regulators and tech giants are caught in a high-stakes patent showdown. The outcome could determine who owns the future of wearable wellness.**
Source & Credit: https://www.macrumors.com/2025/08/21/apple-blood-oxygen-workaround-new-lawsuit/
